Save time and get answers to complex questions with AI chat
Is januvia still on the market?Defense strategy against generic in niche market?Patent expiration eu dabrafenib?Tracleer online pharmacy?Patent term adjustment semaglutida?
See the DrugPatentWatch profile for Aristada
Yes. Aristada (aripiprazole lauroxil) is a long-acting injectable (LAI). It’s designed to release the medicine slowly over time rather than requiring frequent daily dosing.
Aristada is given as an injection on a set schedule (for example, monthly or other interval options depending on the prescribed regimen), which is the main difference from oral, daily aripiprazole.
Because it’s a long-acting injectable, patients generally receive doses less often, and missed doses tend to affect treatment continuity differently than with pills. The exact timing of when the next injection is due depends on the specific Aristada dosing schedule your clinician prescribes.
Other Questions About Aristada :